Among all 10 prognostic specific immune-related genes, 4 genes (AKT1, EPO, MUC4, VEGFC) (25–29) were considered as important predictors of relapse-free or overall survival and were implicated in immune microenvironment-related pathogenesis of cholangiocarcinoma. Here, EPO is linked to cholangiocarcinoma.